IQVIQVIA
$271.73+26% 1Y
$271.73
$156.6652 weeks$279.21
Operating metrics
R&D Solutions contracted backlog at IQVIA: $32.6B for Q3 2026, +0.62% on a year ago.
Operating metrics
From earnings releases, Q3 2021 to Q3 2026
R&D Solutions contracted backlog, Q3 2026+0.62% on a year ago$32.6B
+0.62% on a year ago
R&D Solutions contracted backlog, Q3 2026: $32.6B
“R&DS contracted backlog was $32.6 billion. The company expects approximat...”
Source: Q3 2026 earnings release, filed Oct 27, 2026Every quarter, with its source
| Quarter | R&D Solutions contracted backlog | Release |
|---|---|---|
| Q3 2026 | $32.6B | Filed Oct 27, 2026 |
| Q2 2026 | $34.2B | Filed Jul 28, 2026 |
| Q1 2026 | $34.2B | Filed May 5, 2026 |
| Q4 2025 | $32.7B | Filed Feb 5, 2026 |
| Q3 2025 | $32.4B | Filed Oct 28, 2025 |
| Q2 2025 | $32.1B | Filed Jul 22, 2025 |
| Q1 2025 | $31.5B | Filed May 6, 2025 |
| Q4 2024 | $31.1B | Filed Feb 6, 2025 |
| Q3 2024 | $31.1B | Filed Oct 31, 2024 |
| Q2 2024 | $30.6B | Filed Jul 22, 2024 |
| Q1 2024 | $30.1B | Filed May 2, 2024 |
| Q4 2023 | $29.7B | Filed Feb 14, 2024 |
| Q3 2023 | $28.8B | Filed Nov 1, 2023 |
| Q2 2023 | $28.4B | Filed Aug 1, 2023 |
| Q1 2023 | $27.9B | Filed Apr 27, 2023 |
| Q4 2022 | $27.2B | Filed Feb 10, 2023 |
| Q3 2022 | $25.8B | Filed Oct 26, 2022 |
| Q2 2022 | $25.6B | Filed Jul 21, 2022 |
| Q1 2022 | $25.3B | Filed Apr 27, 2022 |
| Q4 2021 | $24.8B | Filed Feb 15, 2022 |
| Q3 2021 | $24.4B | Filed Oct 21, 2021 |
- R&D Solutions contracted backlog
- R&D Solutions contracted backlog at quarter end (including reimbursed expenses until 2025, as the company defines it).
Source: company earnings releases furnished to the SEC on Form 8-K (Item 2.02, Exhibit 99), SEC EDGAR.
Diagnostics & Research
The closest names by size in the same industry